"SARS-Covid-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonNew COVID variant with immune escape potential confirmed in US, 22 other countries - CIDRAP
New COVID variant with immune escape potential confirmed in US, 22 other countries CIDRAP
Coronavirus disease (COVID-19) - World Health Organization (WHO)
Coronavirus disease (COVID-19) World Health Organization (WHO)
Study highlights neurological and psychiatric impacts of long COVID - News-Medical
Study highlights neurological and psychiatric impacts of long COVID News-Medical
Types of COVID-19 Treatment - Centers for Disease Control and Prevention | CDC (.gov)
Types of COVID-19 Treatment Centers for Disease Control and Prevention | CDC (.gov)
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection - Nature
Presence of SARS-CoV-2 in fetal organs via intraamniotic infection Nature
Acetylsalicylic acid disrupts SARS-CoV-2 spike protein glycosylation and selectively impairs bind...
Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron e...
Detecting SARS-CoV-2 in Nursing Home Residents Consistent With Prior Seasons - Infectious Disease...
Detecting SARS-CoV-2 in Nursing Home Residents Consistent With Prior Seasons Infectious Disease Special Edition
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina - Yale School of Medicine
SARS-CoV-2 Causes Buildup of Alzheimer’s-Related Peptides in the Retina Yale School of Medicine
COVID-19: how worried should we be about the Frankenstein variant? | - Institut Pasteur
COVID-19: how worried should we be about the Frankenstein variant? | Institut Pasteur
SARS-CoV-2 B-Cells Surpass Seasonal Coronavirus Clones - Bioengineer.org
SARS-CoV-2 B-Cells Surpass Seasonal Coronavirus Clones Bioengineer.org
Paternal SARS-CoV-2 infection impacts sperm small noncoding RNAs and increases anxiety in offspri...
Staying Up to Date with COVID-19 Vaccines - Centers for Disease Control and Prevention | CDC (.gov)
Staying Up to Date with COVID-19 Vaccines Centers for Disease Control and Prevention | CDC (.gov)
Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)
Statement on the antigen composition of COVID-19 vaccines World Health Organization (WHO)
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure ...
WHO Scientific advisory group issues report on origins of COVID-19 - World Health Organization (WHO)
WHO Scientific advisory group issues report on origins of COVID-19 World Health Organization (WHO)
The mutational landscape of SARS-CoV-2 provides new insight into viral evolution and fitness - Na...
The mutational landscape of SARS-CoV-2 provides new insight into viral evolution and fitness Nature
SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVI...
Association of SARS-CoV-2 vaccination status with risk of influenza-like illness and loss of work...
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its ba...
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base Nature
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Pa...
Study Shows SARS-CoV-2 Corrupts Some White Blood Cells to Suppress Immune System, Suggesting a Path to Severe COVID Johns Hopkins Medicine
Ask the doctors: Research continues regarding long COVID - The Spokesman-Review
Ask the doctors: Research continues regarding long COVID The Spokesman-Review
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies - Nature
The Virtual Lab of AI agents designs new SARS-CoV-2 nanobodies Nature
Viruses That Jump to Humans Don't Need Special Mutations, Study Finds - ScienceAlert
Viruses That Jump to Humans Don't Need Special Mutations, Study Finds ScienceAlert
Bat Virus Evolution Suggests Wildlife Trade Sparked COVID-19 Virus Emergence in Humans - UC San D...
Bat Virus Evolution Suggests Wildlife Trade Sparked COVID-19 Virus Emergence in Humans UC San Diego Today
Long COVID after SARS-CoV-2 during pregnancy in the United States - Nature
Long COVID after SARS-CoV-2 during pregnancy in the United States Nature
Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)
Statement on the antigen composition of COVID-19 vaccines World Health Organization (WHO)
A systems biology approach to define SARS-CoV-2 correlates of protection - Nature
A systems biology approach to define SARS-CoV-2 correlates of protection Nature
National flu and COVID-19 surveillance report: 12 March 2026 (week 11) - GOV.UK
National flu and COVID-19 surveillance report: 12 March 2026 (week 11) GOV.UK
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - The New En...
Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras The New England Journal of Medicine
SARS-CoV-2 fragments may cause problems after infection - National Institutes of Health (.gov)
SARS-CoV-2 fragments may cause problems after infection National Institutes of Health (.gov)
COVID-19 (SARS-CoV-2 virus) - Institut Pasteur
COVID-19 (SARS-CoV-2 virus) Institut Pasteur
Coronavirus disease (COVID-19) - World Health Organization (WHO)
Coronavirus disease (COVID-19) World Health Organization (WHO)
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children - The New England...
Pre–Covid-19, SARS-CoV-2–Negative Multisystem Inflammatory Syndrome in Children The New England Journal of Medicine
Characteristics of SARS-CoV-2 and COVID-19 - Nature
Widespread exposure to SARS-CoV-2 in wildlife communities - Nature
Widespread exposure to SARS-CoV-2 in wildlife communities Nature
SARS-CoV-2 infection and persistence in the human body and brain at autopsy - Nature
SARS-CoV-2 infection and persistence in the human body and brain at autopsy Nature
SARS-CoV-2 restructures host chromatin architecture - Nature
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics - Nature
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Nature
Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States - Nature
Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States Nature
Transmission of SARS-CoV-2: implications for infection prevention precautions - World Health Orga...
Transmission of SARS-CoV-2: implications for infection prevention precautions World Health Organization (WHO)
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets - Nature
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets Nature
Tracking SARS-CoV-2 variants - World Health Organization (WHO)
Tracking SARS-CoV-2 variants World Health Organization (WHO)
How SARS-CoV-2 Evolved Through the COVID Pandemic - WCM Newsroom
How SARS-CoV-2 Evolved Through the COVID Pandemic WCM Newsroom
The proximal origin of SARS-CoV-2 - Nature
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels - ...
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels Nature
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... - Centers for Disease Control and Preve...
Outbreak of SARS-CoV-2 Infections, including COVID-19 ... Centers for Disease Control and Prevention | CDC (.gov)
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic a...
Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture Science | AAAS
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections - Nature
Using big sequencing data to identify chronic SARS-Coronavirus-2 infections Nature
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 - Nature
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19 Nature
Long COVID after breakthrough SARS-CoV-2 infection - Nature
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows - Centers for Disease Control and Prevention |...
SARS-CoV-2 Variant XEC Increases as KP.3.1.1 Slows Centers for Disease Control and Prevention | CDC (.gov)
SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19...
SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19 Nature
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic - Nature
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic Nature
SARS-CoV-2 pathogenesis - Nature
SARS-CoV-2 pathogenesis Nature
How does SARS-CoV-2 cause COVID-19? - Science | AAAS
How does SARS-CoV-2 cause COVID-19? Science | AAAS
Lab Leak: The True Origins of Covid-19 - The White House (.gov)
Lab Leak: The True Origins of Covid-19 The White House (.gov)
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-se...
The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and nam...
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site - Frontiers
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site Frontiers
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 - The New England Journa...
Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19 The New England Journal of Medicine
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection - The New England...
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection The New England Journal of Medicine
Severe Acute Respiratory Syndrome (SARS) - World Health Organization (WHO)
Severe Acute Respiratory Syndrome (SARS) World Health Organization (WHO)
Gene Analysis Suggests COVID-19 Virus Emerged Naturally, Not From Lab - National Today
Gene Analysis Suggests COVID-19 Virus Emerged Naturally, Not From Lab National Today
Emergence of a Highly Fit SARS-CoV-2 Variant - The New England Journal of Medicine
Emergence of a Highly Fit SARS-CoV-2 Variant The New England Journal of Medicine
SARS-CoV-2 Variants in Patients with Immunosuppression - The New England Journal of Medicine
SARS-CoV-2 Variants in Patients with Immunosuppression The New England Journal of Medicine
Why was the origin of SARS-CoV-2 in question? - Johns Hopkins Bloomberg School of Public Health
Why was the origin of SARS-CoV-2 in question? Johns Hopkins Bloomberg School of Public Health
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-i...
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 Science | AAAS
Mechanisms of SARS-CoV-2 entry into cells - Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) - Nature
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) Nature
Animals and COVID-19 - Centers for Disease Control and Prevention | CDC (.gov)
Animals and COVID-19 Centers for Disease Control and Prevention | CDC (.gov)
Impact of SARS-CoV-2 infection on respiratory and gut microbiome stability: a metagenomic investi...
Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vacc...
Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees Science | AAAS
SARS-CoV-2 can cause lasting damage to cells' energy production - National Institutes of Health (...
SARS-CoV-2 can cause lasting damage to cells' energy production National Institutes of Health (.gov)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug develo...
SARS-CoV-2 vaccines in development - Nature
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 - The New England Journal...
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 The New England Journal of Medicine
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron - Nature
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron Nature
SARS-CoV-2 Variants and Vaccines | New England Journal of Medicine - The New England Journal of M...
SARS-CoV-2 Variants and Vaccines | New England Journal of Medicine The New England Journal of Medicine
Prevalence of persistent SARS-CoV-2 in a large community surveillance study - Nature
Prevalence of persistent SARS-CoV-2 in a large community surveillance study Nature
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England - Science | AAAS
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Science | AAAS
Coronavirus biology and replication: implications for SARS-CoV-2 - Nature
Coronavirus biology and replication: implications for SARS-CoV-2 Nature
Detection of Covid-19 Outbreaks Using Built Environment Testing for SARS-CoV-2 - NEJM Evidence
Detection of Covid-19 Outbreaks Using Built Environment Testing for SARS-CoV-2 NEJM Evidence
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic...
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Nature
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 ...
Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 | MMWR Centers for Disease Control and Prevention | CDC (.gov)
First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020 | ...
First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020 | MMWR Centers for Disease Control and Prevention | CDC (.gov)
The evolution of SARS-CoV-2 - Nature
The evolution of SARS-CoV-2 Nature
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection - Nature
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection Nature
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months wi...
Tracking the evolution of anti-SARS-CoV-2 antibodies and long-term humoral immunity within 2 year...
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronav...
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls - Nature
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls Nature
Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature
Acute and postacute sequelae associated with SARS-CoV-2 reinfection Nature
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory ...
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects - Frontiers
Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects Frontiers
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in verteb...
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 - The New England Journal...
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 The New England Journal of Medicine
SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner - Nature
SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner Nature
Structures and functions of coronavirus replication–transcription complexes and their relevance f...
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine The New England Journal of Medicine